These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


55 related items for PubMed ID: 17192461

  • 1. Involvement of apolipoprotein E in excess fat accumulation and insulin resistance.
    Gao J, Katagiri H, Ishigaki Y, Yamada T, Ogihara T, Imai J, Uno K, Hasegawa Y, Kanzaki M, Yamamoto TT, Ishibashi S, Oka Y.
    Diabetes; 2007 Jan; 56(1):24-33. PubMed ID: 17192461
    [Abstract] [Full Text] [Related]

  • 2. VLDL induces adipocyte differentiation in ApoE-dependent manner.
    Chiba T, Nakazawa T, Yui K, Kaneko E, Shimokado K.
    Arterioscler Thromb Vasc Biol; 2003 Aug 01; 23(8):1423-9. PubMed ID: 12842848
    [Abstract] [Full Text] [Related]

  • 3. Endogenous ApoE expression modulates adipocyte triglyceride content and turnover.
    Huang ZH, Reardon CA, Mazzone T.
    Diabetes; 2006 Dec 01; 55(12):3394-402. PubMed ID: 17130485
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity.
    Kypreos KE, Karagiannides I, Fotiadou EH, Karavia EA, Brinkmeier MS, Giakoumi SM, Tsompanidi EM.
    FEBS J; 2009 Oct 01; 276(20):5720-8. PubMed ID: 19754875
    [Abstract] [Full Text] [Related]

  • 5. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr.
    Lloyd DJ, McCormick J, Helmering J, Kim KW, Wang M, Fordstrom P, Kaufman SA, Lindberg RA, Véniant MM.
    Am J Physiol Endocrinol Metab; 2008 Mar 01; 294(3):E496-505. PubMed ID: 18160459
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice.
    Karagiannides I, Abdou R, Tzortzopoulou A, Voshol PJ, Kypreos KE.
    FEBS J; 2008 Oct 01; 275(19):4796-809. PubMed ID: 18754772
    [Abstract] [Full Text] [Related]

  • 7. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism.
    Santos SH, Fernandes LR, Mario EG, Ferreira AV, Pôrto LC, Alvarez-Leite JI, Botion LM, Bader M, Alenina N, Santos RA.
    Diabetes; 2008 Feb 01; 57(2):340-7. PubMed ID: 18025412
    [Abstract] [Full Text] [Related]

  • 8. Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice.
    Atkinson RD, Coenen KR, Plummer MR, Gruen ML, Hasty AH.
    Am J Physiol Endocrinol Metab; 2008 Feb 01; 294(2):E284-90. PubMed ID: 18029445
    [Abstract] [Full Text] [Related]

  • 9. The transport of triglycerides through the secretory pathway of hepatocytes is impaired in apolipoprotein E deficient mice.
    Mensenkamp AR, Van Luyn MJ, Havinga R, Teusink B, Waterman IJ, Mann CJ, Elzinga BM, Verkade HJ, Zammit VA, Havekes LM, Shoulders CC, Kuipers F.
    J Hepatol; 2004 Apr 01; 40(4):599-606. PubMed ID: 15030975
    [Abstract] [Full Text] [Related]

  • 10. Nutritional regulation of adipose tissue apolipoprotein E expression.
    Huang ZH, Luque RM, Kineman RD, Mazzone T.
    Am J Physiol Endocrinol Metab; 2007 Jul 01; 293(1):E203-9. PubMed ID: 17389709
    [Abstract] [Full Text] [Related]

  • 11. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
    Hsieh PS, Jin JS, Chiang CF, Chan PC, Chen CH, Shih KC.
    Obesity (Silver Spring); 2009 Jun 01; 17(6):1150-7. PubMed ID: 19247274
    [Abstract] [Full Text] [Related]

  • 12. IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions.
    Matsuki T, Horai R, Sudo K, Iwakura Y.
    J Exp Med; 2003 Sep 15; 198(6):877-88. PubMed ID: 12975454
    [Abstract] [Full Text] [Related]

  • 13. Metabolic implications of dietary trans-fatty acids.
    Dorfman SE, Laurent D, Gounarides JS, Li X, Mullarkey TL, Rocheford EC, Sari-Sarraf F, Hirsch EA, Hughes TE, Commerford SR.
    Obesity (Silver Spring); 2009 Jun 15; 17(6):1200-7. PubMed ID: 19584878
    [Abstract] [Full Text] [Related]

  • 14. Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.
    Yu XX, Pandey SK, Booten SL, Murray SF, Monia BP, Bhanot S.
    Am J Physiol Endocrinol Metab; 2008 Mar 15; 294(3):E530-9. PubMed ID: 18198353
    [Abstract] [Full Text] [Related]

  • 15. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance.
    Netea MG, Joosten LA, Lewis E, Jensen DR, Voshol PJ, Kullberg BJ, Tack CJ, van Krieken H, Kim SH, Stalenhoef AF, van de Loo FA, Verschueren I, Pulawa L, Akira S, Eckel RH, Dinarello CA, van den Berg W, van der Meer JW.
    Nat Med; 2006 Jun 15; 12(6):650-6. PubMed ID: 16732281
    [Abstract] [Full Text] [Related]

  • 16. Generation and characterization of a mouse model of the metabolic syndrome: apolipoprotein E and aromatase double knockout mice.
    Scott NJ, Cameron VA, Raudsepp S, Lewis LK, Simpson ER, Richards AM, Ellmers LJ.
    Am J Physiol Endocrinol Metab; 2012 Mar 01; 302(5):E576-84. PubMed ID: 22185842
    [Abstract] [Full Text] [Related]

  • 17. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines.
    Kang L, Sebastian BM, Pritchard MT, Pratt BT, Previs SF, Nagy LE.
    Alcohol Clin Exp Res; 2007 Sep 01; 31(9):1581-8. PubMed ID: 17624994
    [Abstract] [Full Text] [Related]

  • 18. Alcohol consumption promotes insulin sensitivity without affecting body fat levels.
    Hong J, Smith RR, Harvey AE, Núñez NP.
    Int J Obes (Lond); 2009 Feb 01; 33(2):197-203. PubMed ID: 19125162
    [Abstract] [Full Text] [Related]

  • 19. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC, Simari RD, Conover CA.
    Circ Res; 2007 Jun 22; 100(12):1696-702. PubMed ID: 17510462
    [Abstract] [Full Text] [Related]

  • 20. Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein E.
    Clough MH, Schneider DJ, Sobel BE, White MF, Wadsworth MP, Taatjes DJ.
    J Histochem Cytochem; 2005 May 22; 53(5):603-10. PubMed ID: 15872053
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.